DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,247,893 | -0.4% | 13,091 | -3.6% | 0.76% | +5.0% |
| Q2 2023 | $3,259,680 | -8.8% | 13,582 | -4.2% | 0.73% | -11.7% |
| Q1 2023 | $3,574,931 | -8.9% | 14,184 | -4.0% | 0.82% | -8.4% |
| Q4 2022 | $3,922,385 | +1.9% | 14,778 | -0.8% | 0.90% | -4.4% |
| Q3 2022 | $3,849,000 | +0.1% | 14,901 | -1.8% | 0.94% | +72.0% |
| Q2 2022 | $3,845,000 | -13.4% | 15,169 | +0.2% | 0.55% | +1.9% |
| Q1 2022 | $4,439,000 | -3.6% | 15,132 | +8.2% | 0.54% | -5.0% |
| Q4 2021 | $4,603,000 | +8.0% | 13,991 | -0.1% | 0.56% | -0.5% |
| Q3 2021 | $4,264,000 | +12.1% | 14,005 | -1.2% | 0.57% | +13.4% |
| Q2 2021 | $3,804,000 | +16.3% | 14,175 | -2.5% | 0.50% | +8.9% |
| Q1 2021 | $3,272,000 | -1.8% | 14,539 | -3.1% | 0.46% | -6.5% |
| Q4 2020 | $3,332,000 | -41.1% | 14,998 | -42.9% | 0.49% | -49.0% |
| Q3 2020 | $5,655,000 | +21.9% | 26,261 | +0.1% | 0.96% | +17.6% |
| Q2 2020 | $4,639,000 | +21.5% | 26,236 | -4.9% | 0.82% | +3.9% |
| Q1 2020 | $3,819,000 | -8.9% | 27,592 | +1.0% | 0.79% | +13.9% |
| Q4 2019 | $4,191,000 | +5.5% | 27,306 | -0.7% | 0.69% | +5.5% |
| Q3 2019 | $3,972,000 | -0.1% | 27,498 | -1.2% | 0.66% | -0.5% |
| Q2 2019 | $3,976,000 | +5.2% | 27,824 | -2.8% | 0.66% | +0.9% |
| Q1 2019 | $3,779,000 | +29.7% | 28,629 | +1.3% | 0.65% | +16.2% |
| Q4 2018 | $2,914,000 | -6.6% | 28,263 | -1.6% | 0.56% | +7.1% |
| Q3 2018 | $3,121,000 | +8.8% | 28,725 | -1.2% | 0.52% | +5.4% |
| Q2 2018 | $2,869,000 | -1.9% | 29,074 | -2.6% | 0.50% | -3.1% |
| Q1 2018 | $2,924,000 | +4.9% | 29,865 | -0.6% | 0.51% | +12.7% |
| Q4 2017 | $2,788,000 | +0.6% | 30,041 | -7.0% | 0.46% | -1.7% |
| Q3 2017 | $2,771,000 | -3.2% | 32,303 | -4.8% | 0.46% | -2.5% |
| Q2 2017 | $2,864,000 | -3.6% | 33,930 | -2.3% | 0.48% | -4.4% |
| Q1 2017 | $2,972,000 | +13.6% | 34,746 | +3.3% | 0.50% | +6.7% |
| Q4 2016 | $2,617,000 | -2.2% | 33,628 | -1.5% | 0.47% | -6.4% |
| Q3 2016 | $2,676,000 | -29.0% | 34,136 | -8.5% | 0.50% | -29.7% |
| Q2 2016 | $3,770,000 | +8.5% | 37,327 | +1.9% | 0.71% | +8.6% |
| Q1 2016 | $3,475,000 | -3.2% | 36,629 | -5.2% | 0.65% | -6.5% |
| Q4 2015 | $3,590,000 | +2.7% | 38,655 | -5.8% | 0.70% | +5.8% |
| Q3 2015 | $3,497,000 | -4.5% | 41,041 | -4.0% | 0.66% | +3.1% |
| Q2 2015 | $3,660,000 | +5.3% | 42,773 | +4.5% | 0.64% | +4.6% |
| Q1 2015 | $3,477,000 | +0.4% | 40,949 | +1.3% | 0.61% | -2.7% |
| Q4 2014 | $3,463,000 | +17.6% | 40,404 | +4.2% | 0.63% | +10.8% |
| Q3 2014 | $2,944,000 | -1.8% | 38,758 | +1.8% | 0.57% | -1.4% |
| Q2 2014 | $2,997,000 | +3.0% | 38,069 | -1.9% | 0.58% | +2.3% |
| Q1 2014 | $2,910,000 | +210.6% | 38,808 | +219.7% | 0.56% | +197.4% |
| Q4 2013 | $937,000 | +76.5% | 12,137 | +58.4% | 0.19% | +65.8% |
| Q3 2013 | $531,000 | – | 7,661 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |